The migration tool rewrites complex routines into PostgreSQL cursors, but application teams must also change testing and data ...

Discover the best open-source vulnerability scanners of 2026 that help CIOs minimize security costs while ensuring robust protection against software vulnerabilities. Learn about their features and ...

Recursive’s $400 million outlay represents the bulk of the company’s fundraising to date.

Recursion, Roche, and its Genentech subsidiary have announced plans to co-develop a neuroscience discovery program based on ...

Recursion Pharmaceuticals' partnerships, notably with Genentech/Roche and Sanofi, have delivered $500M+ in milestone payments ...

Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

We are no longer just discussing the potential of our platform." (CEO, President & Director Najat Khan) "We now have 5 clinical stage programs, including REC-4881 in FAP, where we have generated some ...